China Pharma Holding (STU:XQJ) FCF Yield %: 0.38 (As of Jul. 11, 2026) — 76% Below Median


STU:XQJ China Pharma Holding Inc STU:XQJ
26 GF Score
Price €26.80
GF Value €10.05
! 3 Warning Signs
View Full Analysis

What is China Pharma Holding FCF Yield %?

China Pharma Holding STU:XQJ 26 FCF Yield % is 0.38 as of Jul. 11, 2026, which is 76% below its 10-year median of 1.59. GuruFocus rates STU:XQJ with a GF Score™ of 26/100 and a GF Value™ of €10.05. The stock has 3 warning signs investors should review. Among 1,007 Drug Manufacturers companies, China Pharma Holding ranks worse than 52.14% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, China Pharma Holding's Trailing 12-Month Free Cash Flow is €0.08 Mil, and Market Cap is €20.28 Mil. Therefore, China Pharma Holding's FCF Yield % for today is 0.38%.

The historical rank and industry rank for China Pharma Holding's FCF Yield % or its related term are showing as below:

STU:XQJ' s FCF Yield % Range Over the Past 10 Years
Min: -94.16   Med: 1.59   Max: 27.38
Current: 0.38


During the past 13 years, the highest FCF Yield % of China Pharma Holding was 27.38%. The lowest was -94.16%. And the median was 1.59%.

STU:XQJ's FCF Yield % is ranked worse than
52.14% of 1007 companies
in the Drug Manufacturers industry
Industry Median: 0.66 vs STU:XQJ: 0.38

China Pharma Holding's FCF Margin % for the quarter that ended in Mar. 2026 was -5.64%.


China Pharma Holding FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


China Pharma Holding FCF Yield % Related Terms


China Pharma Holding FCF Yield % Historical Data

* Premium members only.

The historical data trend for China Pharma Holding's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Pharma Holding FCF Yield % Chart

China Pharma Holding Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.07 -11.50 -2.29 -0.76 0.00

China Pharma Holding Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.56 1.08 -0.70 0.12 -0.02

STU:XQJ vs TXMD, RMTI, AYTU: FCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Pharma Holding FCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's FCF Yield % distribution charts can be found below:

* The bar in red indicates where China Pharma Holding's FCF Yield % falls into.


STU:XQJ
26GF Score
China Pharma Holding Inc STU:XQJ
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Pharma Holding FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

China Pharma Holding's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=0.009 / 415.9896
=0.00%

China Pharma Holding's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.048 * 4 / 1085.9896
=-0.02%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 0.38 mean?
China Pharma Holding (STU:XQJ) has a FCF Yield % of 0.38 as of Jul. 11, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on China Pharma Holding and its competitors. This is 76% below median its historical median of 1.59. According to the industry distribution chart, China Pharma Holding ranks #525 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 52.1%.
Is China Pharma Holding's FCF Yield % too high?
China Pharma Holding's current FCF Yield % of 0.38 is 76% below median its 10-year median of 1.59. The Drug Manufacturers industry median FCF Yield % is 0.66. China Pharma Holding's value of 0.38 is 42.4% below this industry median. Based on the distribution chart, China Pharma Holding ranks #525 out of 1007 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, China Pharma Holding has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does China Pharma Holding's FCF Yield % compare to TXMD and RMTI?
According to the Drug Manufacturers industry distribution chart, China Pharma Holding ranks #525 out of 1007 companies for FCF Yield %. This places China Pharma Holding in the lower half of its industry. The industry median FCF Yield % is 0.66. China Pharma Holding's value of 0.38 is 42.4% below this benchmark. While the company's 10-year median is 1.59 vs. the industry median of 0.66, China Pharma Holding has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.66, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Pharma Holding's current FCF Yield % of 0.38 is 42.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on China Pharma Holding and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Pharma Holding's current FCF Yield % is 0.38, which is 76% below median its own 10-year median of 1.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Pharma Holding stock overvalued right now?
China Pharma Holding (STU:XQJ) has a current FCF Yield % of 0.38. The stock's GF Value™ is €10.05, compared to a current price of €26.80 — trading 166.7% above its estimated fair value. The current FCF Yield % is 0.38, which is 76% below median its 10-year median of 1.59 and 42.4% below the Drug Manufacturers industry median of 0.66. China Pharma Holding's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For China Pharma Holding (STU:XQJ), the current FCF Yield % is 0.38 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Pharma Holding (STU:XQJ) Overvalued in 2026?

Based on GuruFocus' analysis, China Pharma Holding stock appears to be overvalued. The current stock price of €26.80 is trading 166.7% above its estimated GF Value™ of €10.05.

Key valuation signals for STU:XQJ:

  • FCF Yield %: 0.38 (76% below median its 10-year median of 1.59)
  • GF Value™: €10.05 vs. price of €26.80 (166.7% above fair value)
  • GF Score™: 26/100 with 3 warning signs
  • Industry Position: 42.4% below the Drug Manufacturers median (#525 of 1007)

No single metric tells the full story. See the STU:XQJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Pharma Holding Business Description

Other Exchanges CPHI:USA
Address No. 17, Jinpan Road, Second Floor, Jiahai Building, Hainan Province, Haikou, CHN, 570216
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
26GF Score

Get the complete analysis for STU:XQJ

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€26.80
Price
€10.05
GF Value